The DILfrequency study is an adaptive trial to identify optimal IL-2 dosing in patients with type 1 diabetes
The DILfrequency study is an adaptive trial to identify optimal IL-2 dosing in patients with type 1 diabetes
description
scientific article published on 04 October 2018
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в жовтні 2018
@uk
name
The DILfrequency study is an a ...... patients with type 1 diabetes
@en
The DILfrequency study is an a ...... patients with type 1 diabetes
@nl
type
label
The DILfrequency study is an a ...... patients with type 1 diabetes
@en
The DILfrequency study is an a ...... patients with type 1 diabetes
@nl
prefLabel
The DILfrequency study is an a ...... patients with type 1 diabetes
@en
The DILfrequency study is an a ...... patients with type 1 diabetes
@nl
P2093
P1433
P1476
The DILfrequency study is an a ...... patients with type 1 diabetes
@en
P2093
Adrian P Mander
Eleonora Seelig
Emma L Arbon
Frank Waldron-Lynch
James Heywood
Jane Kennet
John A Todd
Katerina Anselmiova
Linda S Wicker
P356
10.1172/JCI.INSIGHT.99306
P407
P577
2018-10-04T00:00:00Z